Ambra Stefani, Medical University of Innsbruck, Innsbruck, Austria, discusses the evolution of our understanding of augmentation in restless legs syndrome (RLS) since it was first described in 1996. She emphasizes the importance of early recognition and prevention of augmentation, noting that patients may experience symptoms spreading to other body parts and paradoxical reactions to medication. This interview took place at the Sleep Europe 2024 congress in Seville, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.